Page last updated: 2024-11-12
pyridine triphenylborane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pyridine triphenylborane: an antifouling biocide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10925275 |
SCHEMBL ID | 394177 |
MeSH ID | M0580873 |
Synonyms (10)
Synonym |
---|
AKOS015840382 |
A845690 |
pyridine-triphenylborane |
pyridine; triphenylborane |
SCHEMBL394177 |
DTXSID20448581 |
pyridine triphenylborane |
pyridine;triphenylborane |
boron, triphenyl(pyridine)-, (t-4)- |
P2785 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
" DPB was the most toxic of the degradation products to all four organisms." | ( Toxicity of degradation products of the antifouling biocide pyridine triphenylborane to marine organisms. Fujii, K; Ito, K; Ito, M; Mochida, K; Ojima, D; Onduka, T, 2013) | 0.63 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.31) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |